Antipneumococcal Activities of GAR-936 (A New Glycylcycline) Compared to Those of Nine Other Agents Against Penicillin-Susceptible and -Resistant Pneumococci
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.44.4.1085-1088.2000
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2000
Authors
Publisher
American Society for Microbiology